Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease.
Yun ShenDongjun DaiJingyi LuYufei WangWei ZhuYuqian BaoGang HuJian ZhouPublished in: Cardiovascular diabetology (2020)
Visit-to-visit variability of GA may be an optimal biomarker in relation to LEAD risk among patients with type 2 diabetes.
Keyphrases